Anzeige
Mehr »
Mittwoch, 29.04.2026 - Börsentäglich über 12.000 News
Zuerst +50%… jetzt ein $20M Graphen-Deal
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiMerck partners Remepy in PDURS-focused alliance
DiAI start-up Profluent nabs Lilly as first big pharma partner
DiCan Purdue finally get its bankruptcy plan over the line?
DiGSK eyes October FDA verdict on chronic hep B drug
DiNovartis shares fall as Entresto sales weaken
DiBoehringer/Zealand dual-acting drug causes 16.6% weight loss
MoIntellia files CRISPR drug after historic phase 3 readout
MoLilly's M&A team strikes again with $2.3bn Ajax takeover
MoGSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio
MoLilly falls on slower start for Foundayo versus Wegovy
MoNew NIHR-funded TRC for Parkinson's disease
MoSun sets out $11.75bn takeover play for Organon
FrFDA grants three priority vouchers to psychedelics
FrFDA declines to approve AbbVie's Botox follow-up
FrFDA clears first genetic hearing loss gene therapy
DoTrump's DOJ reschedules medicinal marijuana, increasing access
DoRay's upscaled Series B, and other biofinancings
DoUK Biobank patient data placed on sale in China
DoNovo says oral semaglutide works in diabetic kids
DoUK Biobank patient data stolen and placed on sale in China
DoUK Biobank patient data hacked and placed on sale in China
DoSwiss franc strength puts Roche's results in a poor light
DoSanofi welcomes incoming CEO with sales lift
DoAbbVie makes record investment in North Carolina plant
22.04.MSD cuts $1bn AI tool deal with Google Cloud